Recently, ROCK has beenhighlighted as an interesting target forthe treatment of Alzheimer's Disease (AD). The RhoA/ROCK signaling pathway modulates the hydrolysisof theamyloid-β protein precursor (APP), which causes amyloid-β(Aβ) accumulation and increased neurotoxicity. This evidence concerns the gene RHOA and Alzheimer disease.